PMGC (ELAB) Competitors $4.66 -1.01 (-17.81%) Closing price 04:00 PM EasternExtended Trading$4.70 +0.04 (+0.75%) As of 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ELAB vs. GELS, IMCC, BIVI, TLPH, PHIO, ERNA, BCDA, PCSA, MBIO, and HOOKShould you be buying PMGC stock or one of its competitors? The main competitors of PMGC include Gelteq (GELS), IM Cannabis (IMCC), BioVie (BIVI), Talphera (TLPH), Phio Pharmaceuticals (PHIO), Ernexa Therapeutics (ERNA), BioCardia (BCDA), Heatwurx (PCSA), Mustang Bio (MBIO), and HOOKIPA Pharma (HOOK). These companies are all part of the "pharmaceutical products" industry. PMGC vs. Its Competitors Gelteq IM Cannabis BioVie Talphera Phio Pharmaceuticals Ernexa Therapeutics BioCardia Heatwurx Mustang Bio HOOKIPA Pharma PMGC (NASDAQ:ELAB) and Gelteq (NASDAQ:GELS) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership. Do institutionals and insiders have more ownership in ELAB or GELS? 22.2% of PMGC shares are held by institutional investors. 0.2% of PMGC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, ELAB or GELS? Gelteq has higher revenue and earnings than PMGC. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPMGCN/AN/A-$6.25M-$433.87-0.01Gelteq$100K113.28-$2.33MN/AN/A Does the media prefer ELAB or GELS? In the previous week, PMGC had 5 more articles in the media than Gelteq. MarketBeat recorded 5 mentions for PMGC and 0 mentions for Gelteq. Gelteq's average media sentiment score of 0.93 beat PMGC's score of 0.43 indicating that Gelteq is being referred to more favorably in the news media. Company Overall Sentiment PMGC Neutral Gelteq Positive Is ELAB or GELS more profitable? Gelteq's return on equity of 0.00% beat PMGC's return on equity.Company Net Margins Return on Equity Return on Assets PMGCN/A -62.73% -52.83% Gelteq N/A N/A N/A SummaryGelteq beats PMGC on 5 of the 8 factors compared between the two stocks. Get PMGC News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAB vs. The Competition Export to ExcelMetricPMGCDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$6.92M$16.13B$14.80B$9.68BDividend YieldN/A4.04%3.83%4.54%P/E Ratio-0.0112.6110.3926.40Price / SalesN/A6.875.68206.18Price / CashN/A42.1839.5028.92Price / Book0.402.632.316.06Net Income-$6.25M$951.86M$922.56M$266.05M7 Day Performance-34.41%-0.68%-0.68%-0.07%1 Month Performance-31.72%4.59%3.40%5.83%1 Year Performance-99.64%-0.87%-1.96%17.88% PMGC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELABPMGC0.647 of 5 stars$4.66-17.8%N/A-99.9%$6.92MN/A-0.0118Stock SplitGap DownGELSGelteqN/A$1.27-4.5%N/AN/A$11.99MN/A0.00N/AGap DownIMCCIM Cannabis0.5972 of 5 stars$2.28-0.9%N/A-4.9%$11.97M$39.44M-4.22340Positive NewsShort Interest ↑BIVIBioVie0.4532 of 5 stars$1.59-3.9%N/A-94.5%$11.87MN/A-0.0210Analyst UpgradeGap UpTLPHTalphera2.6521 of 5 stars$0.58+0.1%$5.00+769.6%-48.0%$11.80M$650K-1.4419Short Interest ↓PHIOPhio Pharmaceuticals3.3882 of 5 stars$2.04+2.5%$14.00+586.3%-27.6%$11.69MN/A-0.6310Positive NewsShort Interest ↓ERNAErnexa Therapeutics1.2961 of 5 stars$1.50+4.7%N/A-95.2%$11.47M$580K-0.1810Positive NewsShort Interest ↓Gap UpBCDABioCardia3.1446 of 5 stars$1.94-0.5%$25.00+1,188.7%-35.2%$11.25MN/A-1.0540Positive NewsShort Interest ↑Gap DownPCSAHeatwurx2.5351 of 5 stars$0.22flat$2.00+809.1%-86.3%$11.23MN/A-0.1020Analyst ForecastShort Interest ↑MBIOMustang Bio0.526 of 5 stars$1.53-1.0%N/A-89.3%$11.12MN/A-0.02100Positive NewsShort Interest ↑HOOKHOOKIPA Pharma2.798 of 5 stars$0.90+3.1%$4.50+400.0%-82.6%$10.97M$9.35M-0.15160Short Interest ↑ Related Companies and Tools Related Companies GELS Alternatives IMCC Alternatives BIVI Alternatives TLPH Alternatives PHIO Alternatives ERNA Alternatives BCDA Alternatives PCSA Alternatives MBIO Alternatives HOOK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ELAB) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMGC Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMGC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELAB Stock Alerts